Digestive & Intestinal Remedies Industry Overview
The global digestive & intestinal remedies market size was valued at USD 18.0 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 3.5% from 2022 to 2028.
The market is majorly driven by high demand for over-the-counter products such as zientac, omez, and others. There is an increase in gastrointestinal disorders cases among people. Moreover, increasing cases of inflammatory bowel disease, constipation, irritable bowel syndrome, and gastroesophageal reflux illness are other factors that in turn are boosting market growth over the forecast period.
Gather more insights about the market drivers, restrains and growth of the Global Digestive & Intestinal Remedies Market
Digestive medicines are the most common over-the-counter medicines purchased by people. Moreover, physicians recommend the use of these medicines only after minor health issues such as acidity and other digestive problems. But in various other countries, these medicines are sold directly to the patients without prescription as per their rules and regulations.
Due to the COVID-19 pandemic, the sales of digestive and intestinal remedies were reduced globally. Lockdown measures to control the spread of COVID-19 and better hygiene have frozen the spread of seasonal illnesses, which has reduced the sales of over-the-counter medicines. Various pharmaceutical companies have displayed quarterly earnings reports which showed that a decrease in digestive and intestinal remedies has affected their bottom line sales in the market.
Market growth of the digestive and intestinal remedies is driven by the changes in the natural food habits, shifting physical routine, and changing eating habits. The use of various chemicals and synthetically produced food ingredients is increasing. The increasing consumption of processed food products can contribute to gastrointestinal disorders. Moreover, the eating out trend is on the rise across the world which also significantly gives rise to digestive problems and market growth.
With the technological developments and advancements, more people are getting dependent on digital techniques. The increasing use of technology is leading the daily lives to become less labor-intense and eventually leading to more sedentary. This creates a lack of physical activity and increases obesity along with digestive and intestinal health issues.
Digestive and intestinal remedies market growth is significantly restrained by the increasing consumption of probiotics and prebiotics in the diets. These probiotics and prebiotic products keep a healthy gut and can help with digestive problems. Other fermented food products such as kefir, kombucha, sauerkraut, etc. are also gaining popularity as excellent for digestive health. The increasing consumption of these supplementary food products is likely to impact the market growth over the forecast period.
Browse through Grand View Research’s Pharmaceuticals Industry Research Reports.
- Gastrointestinal Therapeutics Market – The global gastrointestinal therapeutics market size was valued at USD 37.6 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 3.3% from 2023 to 2030.
- Endometriosis Treatment Market – The global endometriosis treatment market size was valued at USD 1,222.2 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 13.5% from 2023 to 2030.
Key Companies profiled:
Some prominent players in the global digestive & intestinal remedies market include
- Bayer Healthcare
- Johnson & Johnson
- GlaxoSmithKline Plc
- Procter & Gamble Co
- Sanofi
- Boehringer Ingelheim GmbH
- Reckitt Benckiser Group Plc (RB)
- Abbott Laboratories Inc.
- Takeda Pharmaceutical Co Ltd
- Menarini Group
Order a free sample PDF of the Digestive & Intestinal Remedies Market Intelligence Study, published by Grand View Research.
Latest Industry Research Outlook 